Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

  • Andrew R. Moore,
  • Malcolm Boyce,
  • Islay A. Steele,
  • Fiona Campbell,
  • Andrea Varro,
  • D. Mark Pritchard

Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

  • Andrew R. Moore, 
  • Malcolm Boyce, 
  • Islay A. Steele, 
  • Fiona Campbell, 
  • Andrea Varro, 
  • D. Mark Pritchard
PLOS
x

As a result of an error in the production process, a duplicate of Figure 5 appears in place of Figure 4. The correct version of Figure 4 is available here:

The legend for Figure 4 is correct.